Abstract:Background: The success rate of transplanted organs from brain-dead cadaver donors is consistently inferior to that of living sources. As cadaver and living unrelated donors are equally genetically disparate with a given recipient, the difference must lie within the donor himself and/or the effects of organ preservation and storage. We have hypothesized that irreversible central nervous system injury may up-regulate proinflammatory mediators and cell surface molecules in peripheral organs to be engrafted, making them more prone to host inflammatory and immunological responses. Methods: Rats undergoing surgically induced acutely increased intracranial pressure (explosive brain death) were followed for 6 hr. Their peripheral tissues were examined by reverse transcriptase polymerase chain reaction and immunohistology, serum factors were assessed by enzyme-linked immunosorbent assay, and the influence of inflammatory molecules in the blood stream was determined by cross-circulation experiments with normal animals. Results: mRNA expression of both lymphocyte- and macrophage-associated products increased dramatically in all tissues. Similar factors in serum were coincidentally increased; these were shown to be active in vivo by cross-circulation with normal animals. The organs of all control groups, including animals with important ischemic injury and with hemorrhagic shock, were negative. Up-regulation of MHC class I and II antigens and the co-stimulatory molecule B7 suggests increased immunogenicity of the peripheral organs. These changes could be inhibited by: (i) administration of a recombinant soluble P-selectin glycoprotein ligand-Ig, a P- and E-selectin antagonist; and (ii) a fusion protein, cytotoxic T lymphocyte antigen 4-Ig, which blocks B7-mediated T-cell co-stimulation. Conclusions: Activation of peripheral organs following explosive brain death may be caused by various interrelated events, including the effects of massive acute central injury, hypotension, and circulating factors. Almost complete suppression of these changes could be produced by biological agents. Such interventions, if reproducible in humans, could improve the quality of organs from "marginal" donors, broadening the criteria for donor acceptance.

Systemic Inflammation Differences in Brain-vs. Circulatory-Dead Donors: Impact on Lung Transplant Recipients

The Hemodynamic Mechanisms of Lung Injury and Systemic Inflammatory Response Following Brain Death in the Transplant Donor

Influence of Donor Type-Donation After Brain Death Versus Donation After Circulatory Death-on Lung Transplant Outcomes

Inflammatory responses in lungs from donation after brain death: Mechanisms and potential therapeutic targets

Lung Biomolecular Profile and Function of Grafts from Donors after Cardiocirculatory Death with Prolonged Donor Warm Ischemia Time

No Evidence of Progressive Proinflammatory Cytokine Storm in Brain-dead Organ Donors—A Time-course Analysis Using Clinical Samples

Expanding the horizons: Uncontrolled donors after circulatory death for lung transplantation-First comparison with brain death donors

[Short-term outcomes of lung transplant recipients using organs from brain death donors]

Donor Pericardial Interleukin and Apolipoprotein Levels May Predict the Outcome after Human Orthotopic Heart Transplantation

Effect of the brain-death process on acute rejection in renal transplantation

The Comparable Efficacy of Lung Donation after Circulatory Death and Brain Death: A Systematic Review and Meta-analysis

Circulating Cell Death Biomarkers May Predict Survival in Human Lung Transplantation

Lung Donation After Controlled Circulatory Determination of Death: A Review of Current Practices and Outcomes

Short-Term Outcomes Of Heart Transplant From Donation After Circulatory Death Versus Donation After Brain Death.

National time trends in mortality and graft survival following liver transplantation from circulatory death or brainstem death donors

Influence of lung donor agonal and warm ischemic times on early mortality: Analyses from the ISHLT DCD Lung Transplant Registry

Donor and recipient risk factors for the development of primary graft dysfunction following lung transplantation

Role of Donor Microbiota in the Development of Primary Graft Dysfunction Following Human Lung Transplantation

Contrasting predictors of severe primary graft dysfunction following transplant for chronic and acute respiratory failure

Clinical Analysis of Lung Transplantation from Donor of Cardiac Death

Effects of explosive brain death on cytokine activation of peripheral organs in the rat